CRSP stock news
This page provides real-time market news, earnings updates, and company announcements related to CRISPR Therapeutics AG (CRSP).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-16 17:08 EST
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows
Finviz2026-02-19 17:33:45
Caribou Biosciences (CRBU)'s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street
Finviz2026-02-20 17:00:48
Intellia Therapeutics to Participate in Upcoming Investor Conferences
Finviz2026-02-24 13:06:44
Here's What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)
Finviz2026-02-28 07:24:44
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
Finviz2026-02-28 15:09:06
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
Finviz2026-02-28 17:01:08
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
Finviz2026-03-02 12:33:44
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Finviz2026-03-03 12:33:14
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-05 21:12:18
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:06:48
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:06:48
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
Finviz2026-03-09 11:03:50
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
Finviz2026-03-09 17:33:53
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
Finviz2026-03-10 11:07:14
Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Finviz2026-03-10 12:06:51
CRSP, SOLQ: Cathie Wood’s ARK ‘Buys the Dip’ in CRISPR and Solana Staking ETF
Tipranks2026-03-11 06:24:27
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Finviz2026-03-11 11:03:53
Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
Finviz2026-03-12 20:06:49
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Finviz2026-03-25 12:03:58
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
Finviz2026-03-27 11:03:57
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
Finviz2026-03-31 12:06:47
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 20:06:43
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
Finviz2026-02-28 15:09:06
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
Finviz2026-02-28 17:01:08
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
Finviz2026-03-02 12:33:44
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Finviz2026-03-03 12:33:14
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-05 21:12:18
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:06:48
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:06:48
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
Finviz2026-03-09 11:03:50
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
Finviz2026-03-09 17:33:53
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
Finviz2026-03-10 11:07:14
Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Finviz2026-03-10 12:06:51
CRSP, SOLQ: Cathie Wood’s ARK ‘Buys the Dip’ in CRISPR and Solana Staking ETF
Tipranks2026-03-11 06:24:27
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Finviz2026-03-11 11:03:53
Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
Finviz2026-03-12 20:06:49
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Finviz2026-03-25 12:03:58
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
Finviz2026-03-27 11:03:57
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
Finviz2026-03-31 12:06:47
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 20:06:43
CRSP stock chart
CRSP stock detailsCRSP stock price change
On the last trading day, CRSP stock closed at 56.86 USD, with a price change of 3.70% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more